In-Stent RestenosisKIM, Michael S; DEAN, Larry S.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 3, pp 190-198, issn 1755-5914, 9 p.Article

How many grails do we need?HOLMES, David R.Circulation (New York, N.Y.). 2004, Vol 109, Num 18, pp 2158-2159, issn 0009-7322, 2 p.Article

Preclinical restenosis models : Challenges and successesTOUCHARD, Arturo G; SCHWARTZ, Robert S.Toxicologic pathology. 2006, Vol 34, Num 1, pp 11-18, issn 0192-6233, 8 p.Conference Paper

Pushing drug-eluting stents into uncharted territory : Simpler than you think-More complex than you imagineROGERS, Campbell; EDELMAN, Elazer R.Circulation (New York, N.Y.). 2006, Vol 113, Num 19, pp 2262-2265, issn 0009-7322, 4 p.Article

Reno, a european postmarket surveillance registry, confirms effectiveness of coronary brachytherapy in routine clinical practiceCOEN, V; SERRUYS, P; SAUERWEIN, W et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 4, pp 1019-1026, issn 0360-3016, 8 p.Article

Mechanisms of post-intervention arterial remodellingGOEL, Shakti A; GUO, Lian-Wang; BO LIU et al.Cardiovascular research. 2012, Vol 96, Num 3, pp 363-371, issn 0008-6363, 9 p.Article

A classification of bifurcation restenosisSGUEGLIA, Gregory A; TODARO, Daniel; CONTE, Micaela et al.International journal of cardiology. 2011, Vol 152, Num 3, pp 385-386, issn 0167-5273, 2 p.Article

New frontiers in interventional cardiologySOUSA, J. Eduardo; COSTA, Marco A; MURAT TUZCU, E et al.Circulation (New York, N.Y.). 2005, Vol 111, Num 5, pp 671-681, issn 0009-7322, 11 p.Article

Preclinical evaluation of drug-eluting stents for peripheral applications: Recommendations from an expert consensus groupSCHWARTZ, Robert S; EDELMAN, Elazer R; GOODE, Jennifer L et al.Circulation (New York, N.Y.). 2004, Vol 110, Num 16, pp 2498-2505, issn 0009-7322, 8 p.Article

Current Status of Drug-Eluting StentsRABER, Lorenz; WINDECKER, Stephan.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 3, pp 176-189, issn 1755-5914, 14 p.Article

Role of endogenous fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formationMATTER, Christian M; CHADJICHRISTOS, Christos E; KWAK, Brenda R et al.Circulation (New York, N.Y.). 2006, Vol 113, Num 15, pp 1879-1887, issn 0009-7322, 9 p.Article

Strut position, blood flow, and drug deposition : Implications for single and overlapping drug-eluting stentsBALAKRISHNAN, Brinda; TZAFRIRI, Abraham R; SEIFERT, Philip et al.Circulation (New York, N.Y.). 2005, Vol 111, Num 22, pp 2958-2965, issn 0009-7322, 8 p.Article

Nanospheres of a bisphosphonate attenuate intimal hyperplasiaCOHEN-SELA, Einat; DANGOOR, David; EPSTEIN, Hila et al.Journal of nanoscience and nanotechnology (Print). 2006, Vol 6, Num 9-10, pp 3226-3234, issn 1533-4880, 9 p.Article

A novel experimental method to estimate stress-strain behavior of intact coronary arteries using intravascular ultrasound (IVUS)TAJADDINI, Azita; KILPATRICK, Deborah L; VINCE, D. Geoffrey et al.Journal of biomechanical engineering. 2003, Vol 125, Num 1, pp 120-123, issn 0148-0731, 4 p.Article

Sirolimus eluting stent restenosis: Impact of angiographic patterns and the treatment factors on angiographic outcomes in contemporary practiceRATHORE, Sudhir; KINOSHITA, Yoshihisa; ASAKURA, Yasushi et al.International journal of cardiology. 2011, Vol 146, Num 3, pp 390-394, issn 0167-5273, 5 p.Article

Ramatroban, a thromboxane A₂ receptor antagonist, prevents macrophage accumulation and neointimal formation after balloon arterial injury in cholesterol-fed rabbitsISHIZUKA, Toshiaki; MATSUMURA, Kouji; MATSUI, Takemi et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 4, pp 571-578, issn 0160-2446, 8 p.Article

All-trans and 9-cis retinoid acids inhibit proliferation, migration, and synthesis of extracellular matrix of human vascular smooth muscle cells by inducing differentiation in vitroJOHST, Ursula; BETSCH, Angelika; WISKIRCHEN, Jakub et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 4, pp 526-535, issn 0160-2446, 10 p.Article

Dosimetric comparison between high-precision external beam radiotherapy and endovascular brachytherapy for coronary artery in-stent restenosisLETER, Edward M; NOWAK, Peter J. C. M; NIEMAN, Koen et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 4, pp 1252-1258, issn 0360-3016, 7 p.Article

Re-angioplasty of in-stent restenosis versus balloon restenoses: a matched pair comparisonWÖHRLE, Jochen; KOCHS, Matthias; VOLLMER, Christian et al.International journal of cardiology. 2004, Vol 93, Num 2-3, pp 257-262, issn 0167-5273, 6 p.Article

Arterial wall strength after endovascular photodynamic therapyGABELER, Edward E. E; VAN HILLEGERSBERG, Richard; SLUITER, Wim et al.Lasers in surgery and medicine. 2003, Vol 33, Num 1, pp 8-15, issn 0196-8092, 8 p.Article

Comparison of two drug-eluting balloons: a report from the SCAAR registryBONDESSON, Per; LAGERQVIST, Bo; JAMES, Stefan K et al.EuroIntervention. 2012, Vol 8, Num 4, pp 444-449, issn 1774-024X, 6 p.Article

Local infusion of the nitric oxide donor SIN-1 after angioplasty: Effects on intimal hyperplasia in porcine coronary arteriesHARNEK, J; ZOUCAS, E; SJUVE, R et al.Acta radiologica (1987). 2003, Vol 44, Num 4, pp 395-402, issn 0284-1851, 8 p.Article

Restenosis Treatments Using Nanoparticle-based Drug Delivery Systems : Nanotechnology in Pharmaceutical DesignZI GU; ROLFE, Barbara E; THOMAS, Anita C et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 35, pp 6330-6339, issn 1381-6128, 10 p.Article

Innate immunity has a dual effect on vascular healing : Suppression and aggravation of neointimal formation and remodeling post-endotoxin challengeEPSTEIN, H; GRAD, E; GOLOMB, M et al.Atherosclerosis. 2008, Vol 199, Num 1, pp 41-46, issn 0021-9150, 6 p.Article

Inflammation and restenosis after percutaneous coronary interventionsTOUTOUZAS, Konstantinos; COLOMBO, Antonio; STEFANADIS, Christodoulos et al.European heart journal. 2004, Vol 25, Num 19, pp 1679-1687, issn 0195-668X, 9 p.Article